Shenzhen Bioeasy Biotechnology Co. Ltd. - Asset Resilience Ratio

Latest as of September 2025: 9.79%

Shenzhen Bioeasy Biotechnology Co. Ltd. (300942) has an Asset Resilience Ratio of 9.79% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read how much debt does Shenzhen Bioeasy Biotechnology Co. Ltd. carry for a breakdown of total debt and financial obligations.

Liquid Assets

CN¥145.05 Million

≈ $21.22 Million USD Cash + Short-term Investments

Total Assets

CN¥1.48 Billion

≈ $216.80 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2019–2024)

This chart shows how Shenzhen Bioeasy Biotechnology Co. Ltd.'s Asset Resilience Ratio has changed over time. See what is Shenzhen Bioeasy Biotechnology Co. Ltd.'s book value for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Shenzhen Bioeasy Biotechnology Co. Ltd.'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 300942 market cap.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥145.05 Million	9.79%
Total Liquid Assets	CN¥145.05 Million	9.79%

Asset Resilience Insights

Limited Liquidity: Shenzhen Bioeasy Biotechnology Co. Ltd. maintains only 9.79% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Shenzhen Bioeasy Biotechnology Co. Ltd. Industry Peers by Asset Resilience Ratio

Compare Shenzhen Bioeasy Biotechnology Co. Ltd.'s asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Fortress Biotech Inc NASDAQ:FBIO	Biotechnology	11.59%
Summit Therapeutics PLC NASDAQ:SMMT	Biotechnology	0.00%
Tubize-Fin BR:TUB	Biotechnology	0.05%
Apellis Pharmaceuticals Inc NASDAQ:APLS	Biotechnology	0.58%
Beijing Tiantan Biological Products Corp Ltd SHG:600161	Biotechnology	8.08%
BrightGene Bio Medical Technology C SHG:688166	Biotechnology	1.00%
BioArctic AB (publ) ST:BIOA-B	Biotechnology	72.35%
Chengzhi Shareholding Co Ltd SHE:000990	Biotechnology	6.73%

Annual Asset Resilience Ratio for Shenzhen Bioeasy Biotechnology Co. Ltd. (2019–2024)

The table below shows the annual Asset Resilience Ratio data for Shenzhen Bioeasy Biotechnology Co. Ltd..

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	20.79%	CN¥302.92 Million ≈ $44.33 Million	CN¥1.46 Billion ≈ $213.23 Million	+11.94pp
2023-12-31	8.85%	CN¥120.03 Million ≈ $17.56 Million	CN¥1.36 Billion ≈ $198.48 Million	-20.67pp
2021-12-31	29.52%	CN¥340.21 Million ≈ $49.78 Million	CN¥1.15 Billion ≈ $168.65 Million	+26.29pp
2019-12-31	3.23%	CN¥20.00 Million ≈ $2.93 Million	CN¥619.67 Million ≈ $90.68 Million	--

pp = percentage points

About Shenzhen Bioeasy Biotechnology Co. Ltd.

SHE:300942 China Biotechnology

Market Cap

$467.67 Million

CN¥3.20 Billion CNY

Market Cap Rank

#12870 Global

#4030 in China

Share Price

CN¥7.89

Change (1 day)

+0.00%

52-Week Range

CN¥7.74 - CN¥13.82

All Time High

CN¥40.28